Skip to main content

Table 1 Summary of clinical characters of enrolled subjects and healthy donors

From: Soluble glucocorticoid-induced tumor necrosis factor receptor regulates Helios expression in myasthenia gravis

Groups

OMG

GMG

HD

p

Number of cases

16

14

14

 

Age (mean ± SD)

36.2 ± 16.7

44.29 ± 9.21

39.14 ± 10.9

0.238

Sex (male/female)

9/7

6/8

6/8

0.6935

QMG score (mean ± SD)

5.36 ± 1.84

16.14 ± 7.37

  

MGFA I

16

0

  

MGFA II

0

5

  

MGFA III

0

6

  

MGFA IV

0

2

  

MGFA V

0

1

  

AchR-Ab positive

14

13

  

MuSK-Ab positive

0

1

  

Seronegtive

2

0

  

Thymoma

0

1

  
  1. No significant differences were observed in age and gender ratio among three groups (p > 0.05)
  2. OMG ocular myasthenia gravis, GMG generalized myasthenia gravis, HD healthy donors, MGFA Myasthenia Gravis Foundation of America Clinical Classification, AchR-Ab nicotinic acetylcholine receptor antibody, MuSK-Ab muscle specific tyrosine kinase antibody